Hansen Medical +21% as FDA clears Magellan 6Fr Robotic Catheter

|About: Hansen Medical, Inc. (HNSN)|By:, SA News Editor

Hansen Medical (HNSN +20.9%) says it received FDA clearance for its smaller diameter Magellan 6Fr Robotic Catheter for peripheral vascular interventions.

Also, HNSN announces the departure of CEO Bruce Barclay; current board member Chris Lowe is appointed interim CEO.